2025-10-09 - Analysis Report
Okay, here's an analysis of Lam Research Corp (LRCX) based on the data you provided.  I will provide the analysis in English, lead with key numbers, and then add context.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** LRCX
*   **Company:** Lam Research Corp (A global supplier of wafer fabrication equipment and services to the semiconductor industry).
*   **LRCX Cumulative Return:** 225.92%
*   **VOO Cumulative Return:** 99.62%
*   **Absolute Deviation:** Currently 148.1 (LRCX significantly outperforms VOO)
*   **Relative Deviation:** 98.3 (LRCX is near its historical high relative to VOO)

**Analysis:** LRCX has significantly outperformed the S&P 500 (VOO) over the period examined. The relative deviation suggests that this outperformance is near the upper end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha  | Beta  | Cap(B) |
|------------|---------|--------|--------|-------|--------|
| 2015-2017  | 84.0%   | 67.8%  | 56.0%  | 0.0   | 23.2   |
| 2016-2018  | 18.0%   | 68.1%  | 3.0%   | 0.1   | 17.2   |
| 2017-2019  | 53.0%   | 82.9%  | 31.0%  | 1.2   | 36.9   |
| 2018-2020  | 66.0%   | 82.9%  | 42.0%  | 1.1   | 59.5   |
| 2019-2021  | 119.0%  | 82.9%  | 73.0%  | 1.0   | 90.7   |
| 2020-2022  | -10.0%  | 79.2%  | -9.0%  | 0.9   | 53.0   |
| 2021-2023  | -13.0%  | 80.4%  | -15.0% | 1.0   | 98.8   |
| 2022-2024  | -52.0%  | 80.4%  | -72.0% | 1.0   | 91.1   |
| 2023-2025  | 137.0%  | 80.4%  | 73.0%  | 0.9   | 179.8  |

**Analysis:**

*   **CAGR:** Shows significant growth over various periods, with a strong rebound recently (2023-2025).  However, there have also been periods of negative growth.
*   **MDD (Maximum Drawdown):**  High MDD values indicate significant potential for losses during downturns. The stock is volatile.
*   **Alpha:**  Generally positive alpha indicates outperformance relative to the market (VOO). Negative alpha means underperformance.
*   **Beta:**  Beta values around 1 suggest that LRCX's volatility is similar to the market.

**2. Recent Price Action**

*   **Current Price:** 142.54
*   **Previous Close:** 140.35
*   **Change:** +1.56 (+1.11%) - Indicates a recent upward price movement.
*   **5-day Moving Average:** 144.97
*   **20-day Moving Average:** 131.44
*   **60-day Moving Average:** 110.81

**Analysis:**

*   The price is currently above the 20-day and 60-day moving averages, which is a bullish signal. However, it is slightly below the 5-day moving average, which could indicate a potential short-term pullback or consolidation.
*   The noticeable change from the previous close indicates a recent positive price surge, likely influenced by the news and analyst updates.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 68.30 (Approaching overbought territory, but not yet extreme)
*   **PPO:** 0.22 (Positive, indicating upward momentum)
*   **Hybrid Signal:** Buy 100% of cash (Very Safe - MRI:0.90) - Suggests a strong buy signal based on the combined indicators.
*   **Recent (20-day) Relative Deviation Change:** +20.2 (Indicates short-term upward trend relative to VOO)
*   **Expected Return:** 14.5% (Projected long-term outperformance vs. S&P 500 if investing now and holding for 2+ years).

**Analysis:**

*   The MRI suggests a medium level of risk, but the Hybrid Signal strongly recommends a buy. This indicates a potentially favorable risk-reward profile.
*   The positive PPO and recent relative deviation change support the upward momentum.
*   The expected return of 14.5% is attractive for long-term investors.
*   The price change from the previous close reflects a recent upward movement, possibly influencing the MRI and Hybrid Signal.

**4. Recent News & Significant Events**

*   **US Lawmakers Urge Broader Ban on Chipmaking Tool Exports to China:** This headline presents a potential risk for LRCX, as it could limit sales to a major market.
*   **Is It Worth Investing in Lam Research (LRCX) Based on Wall Street's Bullish Views?:** This positive sentiment could be driving recent price increases.
*   **ASML, Applied Materials Fall After US Panel Slams China Sales:** This news corroborates the risk associated with potential export restrictions and suggests a negative impact on the sector.
*   **LRCX vs. TSM: Which Semiconductor Stock Is the Better Bet Right Now?:** This comparison may draw investor attention to LRCX.
*   **China gets around U.S. chip export rules, lawmakers warn:** This could mitigate the negative impact of potential export restrictions, but also suggests ongoing trade tensions.
*   **Goldman Sachs Adjusts Lam Research Price Target to $160 From $115, Maintains Buy Rating:** This is a significant positive catalyst, likely contributing to the recent price surge.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (~1.74 on a 1-5 scale)
*   **Target Price:** Average: $122.32 (Significantly *below* the current price, suggesting overvaluation); High: $175.00 (Suggests potential upside)

**Analysis:**

*   Analysts are generally positive on LRCX.  However, the average target price is considerably lower than the current market price, which indicates that the stock might be currently overvalued based on their models.  The Goldman Sachs price target update is a notable exception.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-04-25 | 1.04 | 4.72 B$  |
| 2025-01-31 | 0.93 | 4.38 B$  |
| 2024-10-28 | 0.86 | 4.17 B$  |
| 2024-01-29 | 7.25 | 3.76 B$  |
| 2025-01-31 | 0.72 | 3.76 B$  |

**Analysis:**

* The EPS and revenue figures show some volatility. The high EPS in 2024-01-29 seems to be an outlier.
* Overall, the trend is positive, with recent quarters showing improved revenue and EPS compared to earlier periods.
* The recent positive earnings reports likely contribute to investor confidence and the bullish sentiment.

**6. Financial Information:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $5.17B  | 50.08%        |
| 2025-03-31 | $4.72B  | 49.02%        |
| 2024-12-31 | $4.38B  | 47.37%        |
| 2024-09-30 | $4.17B  | 48.05%        |
| 2024-06-30 | $3.87B  | 47.53%        |

| Quarter    | Equity  | ROE    |
|------------|---------|--------|
| 2025-06-30 | $9.86B  | 17.44% |
| 2025-03-31 | $9.51B  | 13.99% |
| 2024-12-31 | $8.81B  | 13.52% |
| 2024-09-30 | $8.47B  | 13.18% |
| 2024-06-30 | $8.54B  | 11.95% |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue is consistently growing, and the profit margin is healthy, indicating strong operational efficiency.
*   **Equity and ROE:** Equity is steadily increasing, and the ROE is strong and improving, demonstrating efficient use of shareholder equity to generate profits.

**7. Overall Summary**

Lam Research (LRCX) is currently exhibiting strong performance and positive momentum. It has significantly outperformed the S&P 500 historically, and recent price action and market indicators suggest continued upward potential.  The company's financials are solid, with growing revenue, healthy profit margins, and a strong ROE.

**Key Positives:**

*   Significant outperformance vs. S&P 500.
*   Strong recent price momentum.
*   Positive Market Risk Indicator and Hybrid Signal.
*   Increasing revenue and profit margins.
*   Healthy Return on Equity (ROE).
*   Analyst upgrades (e.g., Goldman Sachs).

**Key Risks and Considerations:**

*   Potential impact from restrictions on chipmaking tool exports to China.
*   High MDD, indicating significant volatility.
*   Average analyst target price below current price (potential overvaluation).
*   RSI approaching overbought levels.

**Recommendation:**

Based on the provided data, LRCX appears to be a potentially attractive investment, especially for long-term investors. However, potential investors should be aware of the risks associated with the company's exposure to the Chinese market and its inherent volatility.  The discrepancy between the current price and the average analyst target price warrants further investigation. It would be prudent to conduct further due diligence and consider individual risk tolerance before making any investment decisions.
